GW Researcher Awarded $3.6M to Investigate HIV Antibody Treatments

A GW-led research team is investigating the ability of diverse strains of HIV-1 to escape broadly neutralizing antibodies

WASHINGTON (July 16, 2020) – The National Institutes of Health has awarded $3.6 million to Rebecca Lynch, PhD, assistant professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, to investigate HIV-1 resistance to antibody treatments. To read the full press release, please visit the link below.

Latest News

Congratulations to Paprika Berry, Pedro Gazzinelli and Jada Covington (a PhD student in the IBS program - former rotating student) from the Gazzinelli lab, for advancing to the Top 5 in the GW New Venture Competition in the Healthcare track! Their innovative project, Weigh2Dose, also earned them…
Researchers at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), in collaboration with colleagues in France and Germany, have developed a model organism from a genetically modified parasitic worm to better study neglected tropical disease.
Brita Ostermeier from the Maggirwar Lab awarded "Young Investigator Award for the Most Outstanding Oral Presentation" at the Society on Neuroimmune Pharmacology Conference